Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients

Josef Veselka, Daniela Cerná, Petra Zimolová, Peter Blasko, Jirí Fiedler, Petr Hájek, Martin Maly, David Zemánek, Radka Duchonová, Josef Veselka, Daniela Cerná, Petra Zimolová, Peter Blasko, Jirí Fiedler, Petr Hájek, Martin Maly, David Zemánek, Radka Duchonová

Abstract

Background: Implantation of a carotid artery stent after predilation is a standard approach in the endovascular treatment of carotid artery stenoses. Stenting without predilation may be an alternative approach in a certain subset of patients. The present prospective, single-center registry was designed to evaluate the feasibility and safety of direct carotid artery stenting (DCAS) in high-risk patients.

Methods and results: Symptomatic patients with stenosis >50% and asymptomatic patients with stenosis >70% were eligible for enrolment. Criteria for high-risk patients included: need or history of open heart surgery, history of myocardial infarction, multivessel coronary artery disease, left ventricular dysfunction (ejection fraction < or =40%), severe pulmonary or renal disease, significant contralateral carotid disease, previous endarterectomy, and age > or =80 years. All procedures were performed using a filter protection device. Patients underwent complete clinical examination before and after DCAS and at 30-day follow-up. A total of 83 consecutive patients (45 males, 68+/-9 years, 33% symptomatic) underwent 100 procedures and 103 stents were deployed successfully. The technical success rate of stenting was 100%. Predilation of carotid stenosis was necessary in 1 (1%) procedure. Carotid-artery stenoses before and after DCAS were 80+/-9% and 7+/-9%, respectively. The median fluoroscopic time for DCAS was 7 min. The overall rate of in-hospital major adverse cerebrovascular events (death, stroke, myocardial infarction) was 5% (2 minor strokes, 3 transient attacks). There was 1 (1%) minor stroke within the 30-day follow-up.

Conclusion: DCAS is feasible and can be performed with an acceptable risk in high-risk patients.

Source: PubMed

3
Sottoscrivi